Cardiac Outcomes after Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance without Diabetes

BACKGROUND: Insulin resistance is highly prevalent among patients with atherosclerosis and is associated with an increased risk for myocardial infarction (MI) and stroke. The Insulin Resistance Intervention after Stroke (IRIS) trial demonstrated that pioglitazone decreased the composite risk for fat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circulation
Asıl Yazarlar: Young, Lawrence H., Viscoli, Catherine M., Curtis, Jeptha P., Inzucchi, Silvio E., Schwartz, Gregory G., Lovejoy, Anne M., Furie, Karen L., Gorman, Mark J., Conwit, Robin, Abbott, J. Dawn, Jacoby, Daniel L., Kolansky, Daniel M., Pfau, Steven E., Ling, Frederick S., Kernan, Walter N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511545/
https://ncbi.nlm.nih.gov/pubmed/28246237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.116.024863
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller